List your tool

Head to head · 2026

JADBio vs Tempus AI

Pricing, free plans, ratings, features, pros and cons, side by side. Where one comes out ahead, we mark it.

JADBio

AutoML built specifically for biological and molecular data, aimed at biomarker discovery by researchers rather than…

3.9Free

Visit JADBio (opens JADBio in a new tab)

Tempus AI

Publicly traded on Nasdaq, guiding to $1.6 billion in 2026 revenue

4.3Not listed

Visit Tempus AI (opens Tempus AI in a new tab)

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

  • Lower starting price

    Not comparable

    Not comparable: JADBio does not list a price

  • Free plan

    JADBio

    Only JADBio has one

  • Higher rating

    Tempus AI

    3.9 against 4.3

  • Same job?

    Yes

    Both are Healthcare AI tools

Side by side

Compared onJADBioTempus AI
Our rating3.94.3Better
Starts atFreeNot listed
Free planYesBetterNo
CategoryHealthcare AIHealthcare AI
PlansFreeSee pricing
Key features
  • AutoML tuned for biological and molecular data
  • Biomarker discovery workflows
  • Survival analysis support
  • GUI for researchers plus an API
  • Available on the AWS Marketplace
  • Machine learning applied to genomic and clinical data for precision treatment matching
  • One of the largest connected libraries of clinical and molecular data
  • Publicly traded on Nasdaq under the ticker TEM
  • Q1 2026 revenue of $348.1M, up 36.1% year over year
  • 2026 revenue guidance raised to $1.59-$1.60 billion
Pros
  • Handles omics data properties that break general AutoML tooling
  • Usable by researchers without a data science team
  • Survival analysis included, which general platforms usually lack
  • Publicly reported financials give unusual transparency into scale and growth
  • Massive, growing data library strengthens precision-matching over time
  • Strong, consistent revenue growth across both diagnostics and data segments
Cons
  • A computationally discovered biomarker is a hypothesis, not a finding
  • Independent cohort validation is still required
  • Narrow domain - no use outside life sciences data
  • Pricing runs through insurance billing and enterprise agreements, not published rates
  • Built specifically for precision medicine and oncology, a narrower clinical scope
  • Best suited to institutions already positioned to act on genomic testing results
CompanyJADBioTempus AI, founded 2015

Prices come from each vendor's pricing page, last checked 20260901. Check the vendor before you buy.

FAQ

Questions people ask

Is JADBio better than Tempus AI?

In our reviews JADBio scores 3.9 and Tempus AI scores 4.3. The better pick depends on the job. JADBio: AutoML built specifically for biological and molecular data, aimed at biomarker discovery by researchers rather than data scientists. Tempus AI: Publicly traded on Nasdaq, guiding to $1.6 billion in 2026 revenue.

Which is cheaper, JADBio or Tempus AI?

JADBio: free. Tempus AI: see pricing.

Do JADBio and Tempus AI have free plans?

Only JADBio has a free plan.

More comparisons